Przewlocki G, Leclerc C
Laboratoire de Biologie des Régulations Immunitaires, Institut Pasteur, Paris.
Res Immunol. 1990 Nov-Dec;141(9):839-53. doi: 10.1016/0923-2494(90)90184-z.
We have recently shown that priming mice with allogeneic strain A spleen cells before immunization with (A x B)F1 spleen cells strongly suppresses the cytotoxic T-lymphocyte (CTL) response directed against linked strain B alloantigens. This specific decrease in the CTL responses against the second immunizing alloantigen is associated with a high CTL response against the first priming alloantigen. The suppression of CTL responses against the strain B alloantigens is, however, not due to killing of F1 spleen cells by anti-A CTL, since it was observed after immunization of primed mice with a mixture of (A x B)F1 and B cells. In the present study, attempts were made to determine the relative contribution of H-2 and minor histocompatibility background antigens towards induction of suppression. Our results demonstrate that priming and immunizing spleen cells have only to share H-2 antigens in order to induce a downregulation of CTL responses directed against the linked alloantigens. This indicates that immunity against H-2 antigens is sufficient to induce suppression. However, priming against minor histocompatibility antigens also induces suppression, but only if spleen cells used for priming and immunization share H-2 antigens with the recipient strain. Therefore, the suppression can be induced by priming with non-H-2 antigens but is H-2-restricted. This study has also demonstrated that suppression can be induced by intraperitoneal or subcutaneous administration of allogeneic cells.
我们最近发现,在用(A×B)F1脾细胞免疫之前,先用同种异体A系脾细胞对小鼠进行预刺激,会强烈抑制针对连锁的B系同种抗原的细胞毒性T淋巴细胞(CTL)反应。针对第二种免疫同种抗原的CTL反应的这种特异性降低与针对第一种预刺激同种抗原的高CTL反应相关。然而,针对B系同种抗原的CTL反应的抑制并非由于抗A CTL杀死了F1脾细胞,因为在用(A×B)F1和B细胞的混合物免疫预刺激小鼠后观察到了这种抑制。在本研究中,我们试图确定H-2和次要组织相容性背景抗原在诱导抑制中的相对作用。我们的结果表明,预刺激和免疫的脾细胞只需共享H-2抗原,就能诱导针对连锁同种抗原的CTL反应下调。这表明针对H-2抗原的免疫足以诱导抑制。然而,针对次要组织相容性抗原的预刺激也会诱导抑制,但前提是用于预刺激和免疫的脾细胞与受体品系共享H-2抗原。因此,抑制可由用非H-2抗原进行预刺激诱导,但具有H-2限制性。本研究还表明,通过腹腔内或皮下注射同种异体细胞也可诱导抑制。